Literature DB >> 9763069

Laparoscopic renal cryoablation: initial clinical series.

I S Gill1, A C Novick, J J Soble, G T Sung, E M Remer, J Hale, C M O'Malley.   

Abstract

OBJECTIVES: To present the technique and short-term results of retroperitoneal laparoscopic renal cryoablation.
METHODS: Ten patients underwent laparoscopic renal cryoablation of 11 exophytic renal tumors ranging in size from 1.5 to 3 cm identified on computed tomography. Tumors were located at the upper (3), middle (5), or lower (3) pole of the kidney. Three patients had a solitary kidney. A 3-port retroperitoneal laparoscopic approach was used to create renal cryolesions. Puncture cryoablation was performed with a 4.8-mm cryoprobe. Real-time, endoscopic, steerable, color Doppler ultrasound was used to monitor the evolving cryolesion. All patients have completed a minimum follow-up of 3 months (mean 5.5, range 3 to 9).
RESULTS: Cryoablation was technically successful in all 10 patients (11 tumors). Under ultrasound guidance, the ice ball was intentionally created up to 1 cm beyond the tumor edge with the aim of achieving negative margins. Mean surgical time was 2.4 hours, cryoablation (double freeze-thaw) time 12.9 minutes, cryoprobe tip temperature -186 degrees C, and blood loss 75 mL. Systemic temperature remained unaltered. Hospital stay was less than 23 hours in 9 of 10 patients. Follow-up magnetic resonance imaging at 1 day and 1, 2, and 3 months identified the punched-out, nonenhancing, spontaneously resorbing, renal cryolesion. Follow-up biopsies of the cryoablated tumor site were negative for cancer in the 3 patients who have undergone the biopsy.
CONCLUSIONS: The initial series of laparoscopic renal cryoablation is presented. The retroperitoneoscopic approach, by avoiding the peritoneal cavity, minimizes the chances of the bowel coming in contact with the evolving cryolesion, and the potential sequelae thereof. Laparoscopic renal cryoablation is currently developmental and long-term data are awaited. Nevertheless, it is potentially an attractive addition to available nephron-sparing surgical techniques.

Entities:  

Mesh:

Year:  1998        PMID: 9763069     DOI: 10.1016/s0090-4295(98)00309-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  23 in total

1.  Current limitations of radiofrequency ablation in renal cell carcinoma.

Authors:  Michael A S Jewett
Journal:  Urologe A       Date:  2004-09       Impact factor: 0.639

Review 2.  Results of kidney tumor cryoablation: renal function preservation and oncologic efficacy.

Authors:  Adam C Mues; Jaime Landman
Journal:  World J Urol       Date:  2010-04-23       Impact factor: 4.226

3.  Renal function and oncologic outcomes after cryoablation or partial nephrectomy for tumors in solitary kidneys.

Authors:  Jatinder Goyal; Abhinav Sidana; Christos S Georgiades; Ronald Rodriguez
Journal:  Korean J Urol       Date:  2011-06-17

Review 4.  Laparoscopic renal cryoablation.

Authors:  Marc Schiffman; Amiel Moshfegh; Adam Talenfeld; Joseph J Del Pizzo
Journal:  Semin Intervent Radiol       Date:  2014-03       Impact factor: 1.513

5.  Robot-assisted retroperitoneal renal cryoablation.

Authors:  Manish N Patel; Mani Menon; Craig G Rogers
Journal:  J Robot Surg       Date:  2008-11-11

6.  Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.

Authors:  Kent Perry; Amnon Zisman; Allan J Pantuck; Nicolette Janzen; Peter Schulam; Arie S Belldegrun
Journal:  Rev Urol       Date:  2002

7.  The impact of renal tumor size on the efficacy of laparoscopic renal cryoablation.

Authors:  Byeong Kuk Ham; Sung Gu Kang; Hoon Choi; Young Hwii Ko; Seok Ho Kang; Jun Cheon
Journal:  Korean J Urol       Date:  2010-03-19

8.  Review of the efficacy and safety of radiofrequency ablation for the treatment of small renal masses.

Authors:  Regina El Dib; Naji J Touma; Anil Kapoor
Journal:  Can Urol Assoc J       Date:  2009-04       Impact factor: 1.862

Review 9.  Kidney cancer ablative therapy: indications and patient selection.

Authors:  Daniel S Lehman; Jaime Landman
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

Review 10.  Cryoablation and radiofrequency for kidney tumor.

Authors:  Daniel S Lehman; Jaime Landman
Journal:  Curr Urol Rep       Date:  2008-03       Impact factor: 3.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.